NCT02822235View on ClinicalTrials.gov

Non-interventional Study of Moderate to Severe Inflammatory Bowel Disease in Brazil

CompletedOBSERVATIONAL

Enrollment

407

Participants

Timeline

Start Date

October 11, 2016

Primary Completion Date

February 5, 2018

Study Completion Date

February 19, 2018

Conditions

Inflammatory Bowel Disease

Interventions

OTHER

No Intervention

Trial Locations (13)

Unknown

Salvador

Goiânia

Belo Horizonte

Juiz de Fora

Curitiba

Teresina

Porto Alegre

Botucatu

Ribeirão Preto

Santo André

São José do Rio Preto

Rio de Janeiro

São Paulo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY

NCT02822235 - Non-interventional Study of Moderate to Severe Inflammatory Bowel Disease in Brazil | Biotech Hunter | Biotech Hunter